LiteFold Launches Globally with Experiment-Driven Protein Design

LiteFold has reached general availability, offering its 'Hill Climb Biology' approach to protein design. After a year of platform building, model training, and wet-lab validation with biotech partners, the team argues drug discovery should rely on experiment-driven continuous optimization rather than isolated predictions.

2026-11-02 ~ 2026-11-02 · 2 related posts

• LiteFold goes GA: drug discovery needs experiment-driven hill climbing, not isolated AI predictions — dejavucoder · 2026-11-02
• LiteFold goes generally available with Hill Climb Biology — sidahuj · 2026-11-02